Transcriptome signatures of human neural stem cells derived from LRRK2 gene therapeutic cells

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• The LRRK2 G2019S mutation is a significant genetic factor in Parkinson's disease (PD), affecting neural stem cells (NSCs).
• Aging exacerbates cellular dysfunction in PD, but its interaction with LRRK2 G2019S in NSCs is unclear.
• NSCs are vital for neural homeostasis, with impaired endoplasmic reticulum and mitochondrial function linked to neurodegeneration.

Purpose of the Study:

• To investigate the temporal effects of the LRRK2 G2019S mutation on NSC aging using transcriptomic analysis.
• To elucidate the molecular mechanisms underlying LRRK2 G2019S-associated cellular dysfunction in aging NSCs.
• To assess the therapeutic efficacy of correcting the LRRK2 mutation in affected NSCs.

Main Methods:

• Comprehensive transcriptomic analysis of LRRK2 G2019S-carrying NSCs across passages simulating aging.
• Utilizing BAC DNA-mediated correction to address the LRRK2 mutation.
• Evaluating restoration of cellular processes including ER function, mitochondrial activity, and vesicular trafficking.

Main Results:

• Transcriptomic analysis revealed temporal changes in LRRK2 G2019S NSCs, impacting ER, mitochondrial, and vesicular trafficking pathways.
• BAC DNA-mediated correction reversed these dysregulations, restoring cellular homeostasis in NSCs.
• Aged LRRK2 G2019S NSCs showed exacerbated dysfunction, particularly in epithelial-mesenchymal transition and TGF-β signaling pathways.

Conclusions:

• The LRRK2 G2019S mutation drives age-dependent decline in NSC function through specific molecular pathways.
• Genetic correction of the LRRK2 mutation offers a promising therapeutic strategy for Parkinson's disease.
• Understanding these mechanisms provides insights into PD pathogenesis and potential interventions.